Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...
Analysts at StockNews.com initiated coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research note issued on ...
NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alpha Teknova (TKNO – Research Report), Wave Life Sciences ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions ...
Nevro (NVRO) delivered earnings and revenue surprises of 18.99% and 1.49%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Nevro behaalde een omzet van $ 105,5 miljoen voor het kwartaal, een daling van 9,1% op jaarbasis, maar boven de consensusverwachting van $ 100,18 miljoen. Het bedrijf rapporteerde echter een verlies ...
Investing.com - Nevro Corp (NYSE: NVRO) rapporteerde op dinsdag voor het eerste kwartaal een winst die lager is dan verwacht en een omzet die hoger is dan de voorspellingen.
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
China and Mexico are two of the largest medical equipment manufacturers in the world. The U.S. has imported roughly $10B in ...
Nevro Corp (NYSE:NVRO) is set to release its Q4 2024 earnings on Mar 4, 2025. The consensus estimate for Q4 2024 revenue is ...
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...